4-(1-(2-Fluorophenyl)-1H-pyrazol-4-yl)-N-(isoxazol-3-ylmethyl)pyrimidin-2-amine

Catalog No. :
ACBEPC756
CAS No. :
1227705-01-2
Molecular Formula :
C17H13FN6O
Molecular Weight :
336.33

IUPAC Name:4-(1-(2-fluorophenyl)-1H-pyrazol-4-yl)-N-(isoxazol-3-ylmethyl)pyrimidin-2-amine

4-(1-(2-Fluorophenyl)-1H-pyrazol-4-yl)-N-(isoxazol-3-ylmethyl)pyrimidin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(1-(2-Fluorophenyl)-1H-pyrazol-4-yl)-N-(isoxazol-3-ylmethyl)pyrimidin-2-amine
IUPAC Name4-(1-(2-fluorophenyl)-1H-pyrazol-4-yl)-N-(isoxazol-3-ylmethyl)pyrimidin-2-amine
Molecular FormulaC17H13FN6O
Molecular Weight336.33
SMILESFC1=CC=CC=C1N2N=CC(C3=NC(NCC4=NOC=C4)=NC=C3)=C2
InChI KeyBQGVCNJHRXBGBN-UHFFFAOYSA-N
Synonym4-(1-(2-Fluorophenyl)-1H-pyrazol-4-yl)-N-(isoxazol-3-ylmethyl)pyrimidin-2-amine;2-Pyrimidinamine, 4-[1-(2-fluorophenyl)-1H-pyrazol-4-yl]-N-(3-isoxazolylmethyl)-
CAS No.1227705-01-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBEPC756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOPMT388 route compound structure diagram
    ACOPMT3881402240-89-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBEPC756 route product structure diagram
    ACBEPC7561227705-01-2
Inquiry

2. ACBEPC756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBEPC756 route product structure diagram
    ACBEPC7561227705-01-2
Inquiry

Comments (0)